Intended for healthcare professionals

Rapid response to:

Opinion

Prescribing parkrun: medicalising a walk in the park

BMJ 2025; 389 doi: https://doi.org/10.1136/bmj.r670 (Published 08 April 2025) Cite this as: BMJ 2025;389:r670

Rapid Response:

Re: Prescribing parkrun: medicalising a walk in the park

Dear Editor

We thank the authors for their thoughtful analysis and welcome the chance to discuss the broader implications of “prescribing parkrun” within the context of social prescribing. We agree that parkrun is a remarkable community‐based initiative that demedicalises health promotion, shifting focus away from traditional, command‐driven models toward an empowering, participatory approach. We address several key points raised in the article.

Demedicalising and Empowering through Social Prescribing

Critics argue that using the term “prescribing” implies a top–down model of authority, yet this view overlooks how social prescribing is practised in clinical discussions about group physical activity such as parkrun. The term “prescribing” is aimed at clinicians, legitimising evidence‐based treatment options beyond medications. There is robust evidence that group physical activity improves health outcomes (1), although many clinicians and patients remain unaware of its efficacy compared to medication. By framing physical activity like parkrun as an added treatment option, clinicians support demedicalisation by avoiding unnecessary prescriptions—a practice preferred by patients. Just as forcing medication would be poor practice, dictating behavior is similarly inappropriate and unlikely.

From a patient’s perspective, calling parkrun a prescription is misleading because the event remains free and accessible to all. The term ‘prescribing’ here is meant solely to encourage clinicians to signpost it as a valid option. Facilitating access to this community‐led opportunity to enhance physical and mental health is sound practice, regardless of semantic debates. This aligns with evidence that community‐focused interventions can transform patient engagement by promoting autonomy and self‐directed improvement, especially among marginalised and deprived groups (2).

Evidence of Impact and Cost-Effectiveness

Recent research, including a study by Haake and colleagues from Sheffield Hallam University (3), shows that parkrun participation is linked with statistically significant improvements in life satisfaction over six months. The study reported a weighted, seasonally adjusted increase of 0.26 points in life satisfaction among new participants, with the greatest gains in those previously inactive. The cost‐effectiveness analysis is compelling; benefit‐cost ratios range from 16.7:1 with a conservative estimate to as high as 98.5:1 when broader wellbeing impacts are included. These figures underscore the economic and public health benefits of incorporating social interventions like parkrun into primary care.

Primary Care Engagement and Adoption

It is important to clarify that over 2000 general practices now participate in parkrun practices, not merely 1800 as previously suggested (4). This level of engagement demonstrates that GPs recognise the value of linking patients to community assets. Primary care professionals are championing a shift toward a holistic and preventative approach that de‐emphasises traditional pharmacological treatments in favour of community participation and self‐care.

Countering the Misconception of “Medicalising” Exercise

Critics claiming that “prescribing” parkrun reinforces a hierarchical framework misinterpret social prescribing. Integrating parkrun into primary care promotes a model where community resources, not medications, take centre stage. This approach does not reduce patient autonomy; it provides a flexible, enjoyable option for self‐directed health improvement supported by professional advice. Rather than undermining community exercise, it legitimises parkrun as a vital component of modern, patient‐centred health promotion.

In Summary

In summary, the evidence affirms that parkrun is a paradigm of demedicalisation rather than an overly medicalised intervention. It embodies social prescribing by connecting patients with their communities while delivering measurable improvements in life satisfaction and wellbeing. With over 2000 general practices involved, ‘prescribing’ parkrun is a justified, cost‐effective public health strategy that merits ongoing support and expansion. These findings and practice insights not only reinforce the validity of social prescribing models but also highlight the transformative potential of community‐based health initiatives in reshaping modern primary care. Overall, parkrun integration into primary care offers significant, measurable, and enduring public health advantages globally.

1) Burke, Shauna M., et al. "Group versus individual approach? A meta-analysis of the effectiveness of interventions to promote physical activity." Journal of sport & exercise psychology 2 (2006): 19-35.
2) What works: Community engagement and empowerment to address health inequalities - Health Equity Evidence Centre
3) HAAKE, Steve, QUIRK, Helen and BULLAS, Alice (2024). The impact of parkrun on life satisfaction and its cost-effectiveness: A six-month study of parkrunners in the United Kingdom. PLOS Global Public Health, 4 (10).
4) Royal college of GPs 2000 GP surgeries in the UK now registered to parkrun practices 28 March 2025 https://www.rcgp.org.uk/News/2000-GP-surgeries-registered-parkrun-practices

Competing interests: Dr Hussain Al-Zubaidi: Royal College of GPs Lifestyle and Physical activity champion; parkrun Health Partnerships Lead. Dr Ellen Fallows: British Society of Lifestyle Medicine Vice President.

10 April 2025
Hussain A Al-Zubaidi
GP
Dr Ellen Fallows (Vice President of the British Society of Lifestyle Medicine)
RCGP
30 Euston Square, London NW1 2FB